vcfirmsdirectory.com

Venture capital

ShangBay Capital

Palo Alto venture capital firm investing in medical device, biotechnology and healthcare technology companies through venture equity, with a large portfolio and several exits.

Palo AltoRegistered · Palo Alto
New investments · 12 months
Fund vehiclesPublic
6
6 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: shangbaycapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round ShangBay Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is ShangBay Capital right for your round?

Is ShangBay Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
6
6 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

SHANGBAY CAPITAL III, LLCUS private fund · Active · United States · $84.5M gross assets · filed 4 May 2026
SHANGBAY CAPITAL OPPORTUNITY, LLCUS private fund · Active · United States · $78.3M gross assets · filed 4 May 2026
SHANGBAY CAPITAL II, LLCUS private fund · Active · United States · $59.7M gross assets · filed 4 May 2026
SHANGBAY CAPITAL, LLCUS private fund · Active · United States · $30M gross assets · filed 4 May 2026
SHANGBAY CAPITAL SPV I LLCUS private fund · Active · United States · $7M gross assets · filed 4 May 2026
SHANGBAY CAPITAL V, LLCUS private fund · Active · United States · $2.9M gross assets · filed 4 May 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds ShangBay Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, ShangBay Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

CERIBELLLUCIRA HEALTHARRINEXAPEXIGENBERKELEY LIGHTSDEVORO MEDICALNEUROVASC TECHNOLOGIESARANZ MEDICALCORINTH MEDTECHMODULAR SURGICALand 60 more

Portfolio and exits

Every company ShangBay Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where ShangBay Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet ShangBay Capital

Events where ShangBay Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet ShangBay Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

30 Jul 2026New deal
4 May 2026Fund filingForm ADV filed by SHANGBAY CAPITAL MANAGEMENT COMPANY, LLC: 6 private funds, $262.3M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

ShangBay Capital is based in Palo Alto, United States.

6 fund vehicles are on public registers (SEC adviser filings), including SHANGBAY CAPITAL III, LLC, SHANGBAY CAPITAL OPPORTUNITY, LLC and SHANGBAY CAPITAL II, LLC.

Sectors: Medtech, Biotech, Health tech. From the firm’s own website.

Backs founders building disruptive companies that tackle high, unmet clinical needs with novel ideas. Leverages a leadership team's deep ties to strategics and experienced innovators to help founders meet large market needs and generate favorable returns. From the firm’s own website.

ShangBay Capital lists 70 portfolio companies on its website, including CERIBELL, LUCIRA HEALTH, ARRINEX, APEXIGEN and BERKELEY LIGHTS.

Firms whose websites list some of the same companies include Agent Capital, RA Capital and Gilmartin Capital.

Know before ShangBay Capital’s next round is announced.

PRO tracks ShangBay Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

ShangBay CapitalGet ShangBay Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.